# Risk: __Potential fecal-oral transmission__ (PBN__Risk_1948)

## Property: has_RiskSubject

* [general population](../Stakeholder/PBN__Stakeholder_9)
* [healthcare workers](../Stakeholder/PBN__Stakeholder_68)

## Property: has_RiskISO_Impact

* [Health and care](../RiskISO/PBN__RiskISO_Purpose_0)

## Property: has_RiskSource

* [randazzo_sars-cov-2_2020](../Article/PBN__Article_96)

## Property: has_RiskName

Increased risk of disease transmission and complications.

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

## Property: has_RiskGBN

* [No](../RiskGBN/PBN__RiskGBN_0)

## Property: has_RiskTechnology

* [nan](../Technology/PBN__Technology_22)

## Property: has_RiskOwner

* [public health authorities](../Stakeholder/PBN__Stakeholder_0)
* [researchers](../Stakeholder/PBN__Stakeholder_2)

## Property: has_RiskType

* [health](../RiskType/PBN__RiskType_4)

## Property: has_RiskDescription

The role of secretions in spreading the disease through fecal-oral transmission is not clarified yet.

## Property: has_RiskISO_Purpose

* [Responsible resource use](../RiskISO/PBN__RiskISO_Impact_4)

## Property: has_RiskMitigation

* [Further research and investigation needed to confirm the possibility of fecal-oral transmission route.](../RiskMitigation/PBN__RiskMitigation_2559)

